PAPER Kim M, Jang S, Lee D, Lee S, Gwak J, Jun SC, Kim JG
SEARCH RESULTS
329654 RESULTS
PAPER Pyka P, Haberek W, Więcek M, Szymanska E, Ali W, Cios A, Jastrzębska-Więsek M, Satała G, Podlewska S, Di Giacomo S, Di Sotto A, Garbo S, Karcz T, Lambona C, Marocco F, Latacz G, Sudoł-Tałaj S, Mordyl B, Głuch-Lutwin M, Siwek A, Czarnota-Łydka K, Gogola D, Olejarz-Maciej A, Wilczyńska-Zawal N, Honkisz-Orzechowska E, Starek M, Dąbrowska M, Kucwaj-Brysz K, Fioravanti R, Nasim MJ, Hittinger M, Partyka A, Wesołowska A, Battistelli C, Zwergel C, Handzlik J
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease.
J Med Chem. 2024 Jan 25;67(2):1580-1610. Epub 2024 Jan 8 PubMed: 38190615PAPER Espay AJ, Lees AJ
Are we entering the 'Tau-lemaic' era of Parkinson's disease?
Brain. 2024 Feb 1;147(2):330-332. PubMed: 38190424PAPER Selles MC, Oliveira MM
The Oxytocin Puzzle: Unlocking Alzheimer's Disease.
J Alzheimers Dis. 2024;97(3):1101-1104. PubMed: 38189754PAPER Kotredes KP, Pandey RS, Persohn S, Elderidge K, Burton CP, Miner EW, Haynes KA, Santos DF, Williams SP, Heaton N, Ingraham CM, Lloyd C, Garceau D, O'Rourke R, Herrick S, Rangel-Barajas C, Maharjan S, Wang N, Sasner M, Lamb BT, Territo PR, Sukoff Rizzo SJ, Carter GW, Howell GR, Oblak AL
Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau Pathology.
bioRxiv. 2023 Dec 20; PubMed: 38187716PAPER Burke CM, Mark KM, Kun J, Beauchemin KS, Supattapone S
Correction: Emergence of Prions Selectively Resistant to Combination Drug Therapy.
PLoS Pathog. 2024 Jan;20(1):e1011919. Epub 2024 Jan 8 PubMed: 38190351PAPER Au HD, Lan NT, Binh NT, Linh LT, Hien MM, Duc NM
Sporadic Creutzfeldt-Jakob disease: Brain MRI lesion features from 2 cases reports.
Radiol Case Rep. 2024 Mar;19(3):939-943. Epub 2023 Dec 17 PubMed: 38188942PAPER Lockard G, Gordon J, Schimmel S, Sayed BE, Monsour M, Garbuzova-Davis S, Borlongan CV
Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: An updated review.
Neuroprotection. 2023 Dec;1(2):130-138. Epub 2023 Nov 20 PubMed: 38188233PAPER Hu Z, Zuo C, Mao C, Shi C, Xu Y
Peripheral immune markers and amyotrophic lateral sclerosis: a Mendelian randomization study.
Front Neurosci. 2023;17:1269354. Epub 2023 Dec 21 PubMed: 38188028PAPER Daly T
Alzheimer's research after full approval of lecanemab: impetus and variety.
Dement Neuropsychol. 2023;17:e20230064. Epub 2024 Jan 5 PubMed: 38189032PAPER Kurkinen M
Anti-amyloid therapies do not slow Alzheimer's disease progression.
Dement Neuropsychol. 2023;17:e20230099. Epub 2024 Jan 5 PubMed: 38189031PAPER International BR
Retracted: Intestinal Flora Balance Therapy Based on Probiotic Support Improves Cognitive Function and Symptoms in Patients with Alzheimer's Disease: A Systematic Review and Meta-analysis.
Biomed Res Int. 2023;2023:9817147. Epub 2023 Dec 29 PubMed: 38188841PAPER International BR
Retracted: Herpes Simplex Virus Infection Increases Beta-Amyloid Production and Induces the Development of Alzheimer's Disease.
Biomed Res Int. 2023;2023:9806907. Epub 2023 Dec 29 PubMed: 38188833PAPER International BR
Retracted: An Exploration: Alzheimer's Disease Classification Based on Convolutional Neural Network.
Biomed Res Int. 2023;2023:9787560. Epub 2023 Dec 29 PubMed: 38188832PAPER Wang H, Zhang Z, Hongpaisan J
PKCε activator protects hippocampal microvascular disruption and memory defect in 3×Tg-Alzheimer's disease mice with cerebral microinfarcts.
Front Aging Neurosci. 2023;15:1272361. Epub 2023 Dec 15 PubMed: 38187357Current Filters
- Date Range : All x